Huge news out of the US overnight with the rescheduling of Cannabis imminent. ETFs rose by over 20% within a matter of minutes as investors bought heavily into the industry. Globally speaking, this is a substantial shift in classification. Will Australia follow suit? But at least the agenda is in the news and gaining media attention, usually that is enough to shift investor perception.
Unlikely ECS, as per usual, will see any residual buying here. But one can dream.
ECS Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held
